Thrombolytic Failure with Streptokinase in Acute Myocardial Infarction Using Electrocardiogram Criteria
Thrombolytic Failure with Streptokinase in Acute Myocardial Infarction
DOI:
https://doi.org/10.54393/pjhs.v6i10.3494Keywords:
Streptokinase, ST-segment resolution, Thrombolytic failure, ECG predictors, Rescue PCIAbstract
Streptokinase remains a key thrombolytic agent for ST-elevation myocardial infarction (STEMI) in many low-resource settings. Understanding the rate of thrombolytic failure and its predictors using electrocardiographic criteria is important for optimizing therapeutic strategies. Objectives: To determine the rate of thrombolytic failure in acute myocardial infarction using streptokinase, to describe in-hospital outcomes, and to assess associations between baseline clinical and ECG variables and thrombolytic success. Methods: This prospective observational study was conducted at Lady Reading Hospital, Peshawar. Ninety-three consecutive adult STEMI patients treated with streptokinase within 12 hours of symptom onset were included. Successful reperfusion was defined as >50% ST-segment resolution at 90 minutes. Demographics, risk factors, MI type, Killip class, symptom-to-door categories, and in-hospital outcomes were recorded. Bleeding events were classified using the TIMI criteria. Data were analyzed using the t-test for continuous variables and the chi-square/Fisher’s exact test for categorical variables, with p < 0.05 considered significant. Results: The thrombolytic success rate was 77.4%. Symptom-to-door categories (<3h, 3–6h, >6h) were not significantly associated with reperfusion success. No baseline risk factors or Killip class independently predicted outcome. In-hospital mortality was 2.2%, TIMI major bleeding was 2.2%, and minor bleeding was 6.5%. Rescue PCI was required in 15.1%. Persistent chest pain, reperfusion arrhythmias, and hemodynamic instability occurred in 16.1%, 17.2%, and 14.0% respectively. Conclusion: Streptokinase achieved a high reperfusion rate with low complication rates. Conventional baseline variables did not predict success. Emphasis should remain on early presentation, system-level efficiency, and timely rescue PCI for failures.
References
Geltser BI, Domzhalov IG, Shakhgeldyan KI, Kuksin NS, Kokarev EA, et al. Prediction of Hospital Mortality in Patients with ST Segment Elevation Myocardial Infarction: Evolution of Risk Measurement Techniques and Assessment of Their Effectiveness. Sovremennye Tekhnologii v Meditsine. 2024; 16(4 (eng)): 61-72. doi: 10.17691/stm2024.16.4.07. DOI: https://doi.org/10.17691/stm2024.16.4.07
Rahman A, Momenuzzaman NA, Chowdhury AW, Reza AQ, Munwar S, et al. Exploring the Efficacy of Streptokinase and Tenecteplase: Comparing Thrombolytic, Pharmaco-Invasive Therapy and Primary PCI in ST-Elevated Myocardial Infarction Patients of Bangladesh. European Journal of Medical and Health Sciences. 2025 Mar; 7(2): 41-6. doi: 10.24018/ejmed.2025.7.2.2251. DOI: https://doi.org/10.24018/ejmed.2025.7.2.2251
Sritharan HP, Nguyen H, Ciofani J, Bhindi R, Allahwala UK. Machine-Learning-Based Risk Prediction of In-Hospital Outcomes Following STEMI: The STEMI-ML Score. Frontiers in Cardiovascular Medicine. 2024 Oct; 11: 1454321. doi: 10.3389/fcvm.2024.1454321. DOI: https://doi.org/10.3389/fcvm.2024.1454321
Oraii A, Shafeghat M, Ashraf H, Soleimani A, Kazemian S, et al. Risk Assessment for Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Retrospective Cohort Study. Health Science Reports. 2024 Feb; 7(2): e1867. doi: 10.1002/hsr2.1867. DOI: https://doi.org/10.1002/hsr2.1867
Muoghalu CG, Ekong N, Wyns W, Ofoegbu CC, Newell M, et al. A Systematic Review of the Efficacy and Safety of Tenecteplase versus Streptokinase in the Management of Myocardial Infarction in Developing Countries. Cureus. 2023 Aug; 15(8). doi: 10.7759/cureus.44125. DOI: https://doi.org/10.7759/cureus.44125
Agrawal N, Duraiswami K, Agrawal S, Kalouni A, Singh S, et al. Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients Undergoing Thrombolysis Initiated by Emergency Physicians: A Cross-Sectional Study from India. The American Journal of Emergency Medicine. 2025 Oct; 96: 243-8. doi: 10.1016/j.ajem.2025.07.018. DOI: https://doi.org/10.1016/j.ajem.2025.07.018
Imad M, Khalil AA, Waqar H, Babar FU, Shah SA, et al. Factors Influencing Post-Thrombolytic ST-Segment Resolution in STEMI Patients: A Cross-Sectional Study from Tertiary Care Hospitals. Pakistan Heart Journal. 2025 Mar; 58(1): 79-85. doi: 10.47144/phj.v58i1.2805. DOI: https://doi.org/10.47144/phj.v58i1.2805
Sampat V, Thummar A, Tilara M. Impact of Streptokinase Thrombolysis in STEMI Patients by 2D Echocardiographic Findings. European Journal of Cardiovascular Medicine. 2025 Feb; 15: 383-7.
Roostami T, Farhadian M, Yazdi A, Mahjub H. Risk Factor Analysis and Predictive Nomogram Development for In-Hospital Mortality in Patients with ST-Segment Elevation Myocardial Infarction. BMC Medical Informatics and Decision Making. 2025 Aug; 25(1): 311. doi: 10.1186/s12911-025-03154-w. DOI: https://doi.org/10.1186/s12911-025-03154-w
Ahmad F, Ullah I, Farhad A, Ahmad W, Rauf MA. Thrombolytic Therapy Success Rate and Time to Thrombolysis in Patients with ST-Elevation Myocardial Infarction. Khyber Journal of Medical Sciences. 2024 Jul; 17(2): 88-93. doi: 10.70520/kjms.v17i2.524. DOI: https://doi.org/10.70520/kjms.v17i2.524
Shameem M, Sivakumar R, Komala M, Bargavi BH. Observational Study on the Use of Streptokinase in Patients with Acute Myocardial Infarction and Its Outcome at Discharge. Saudi Journal of Medicine. 2021; 6(4): 65-9. doi: 10.36348/sjm.2021.v06i04.002. DOI: https://doi.org/10.36348/sjm.2021.v06i04.002
Akhtar S and Ashraf A. Frequency of Successful Thrombolysis with Streptokinase in Patients with Acute ST Elevation Myocardial Infarction. Pakistan Heart Journal. 2022 Jul; 55. doi: 10.47144/phj.v55iSupplement1.2426. DOI: https://doi.org/10.47144/phj.v55iSupplement1.2426
Koh HP, Md Redzuan A, Mohd Saffian S, Hassan H, Nagarajah JR, et al. Mortality Outcomes and Predictors of Failed Thrombolysis Following STEMI Thrombolysis in a Non-PCI Capable Tertiary Hospital: A 5-Year Analysis. Internal and Emergency Medicine. 2023 Jun; 18(4): 1169-80. doi: 10.1007/s11739-023-03202-1. DOI: https://doi.org/10.1007/s11739-023-03202-1
de Waha S, Patel MR, Thiele H, Udelson JE, Granger CB, et al. Relationship between Infarct Artery, Myocardial Injury, and Outcomes after Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction. Journal of the American Heart Association. 2024; 13(18): e034748. doi: 10.1161/JAHA.123.034748. DOI: https://doi.org/10.1161/JAHA.123.034748
Shaikh MK, Shah SZ, Kumar C, Lohano M, Talpur AS, et al. Accuracy of Resolution of ST-Segment Elevation in Electrocardiogram to Determine the Patency of Infarct-Related Artery. Cureus. 2021 Apr; 13(4). doi: 10.7759/cureus.14448. DOI: https://doi.org/10.7759/cureus.14448
Wu C, Li L, Wang S, Zeng J, Yang J, et al. Fibrinolytic Therapy Use for ST-Segment Elevation Myocardial Infarction and Long-Term Outcomes in China: 2-Year Results from the China Acute Myocardial Infarction Registry. BMC Cardiovascular Disorders. 2023 Feb; 23(1): 103. doi: 10.1186/s12872-023-03105-1. DOI: https://doi.org/10.1186/s12872-023-03105-1
Ahmad A, Khan I, Iqbal M, Afsar R, Shams S, et al. Impact of Failed Thrombolysis: Clinical Outcomes in a PCI-Capable Setting. Journal of Saidu Medical College Swat. 2025 Jul; 15(3): 380-9. doi: 10.52206/jsmc.2025.15.3.1128. DOI: https://doi.org/10.52206/jsmc.2025.15.3.1128
Subhendu MS, George OK, Prakash JA. Antistreptokinase Antibodies and the Response to Thrombolysis with Streptokinase in Patients with Acute ST Elevation Myocardial Infarction. Heart Asia. 2012; 4(1): 7-10. doi: 10.1136/heartasia-2012-010094. DOI: https://doi.org/10.1136/heartasia-2012-010094
Solanki C, Singh KD, Tripathi SK, Indurkar M, Tikadar RK. Coronary Angiographic Assessment of Streptokinase Efficacy in Young Patients with ST-Elevation Myocardial Infarction. Asian Journal of Medical Sciences. 2025 Feb; 16(2): 63-8. doi: 10.71152/ajms.v16i2.4344. DOI: https://doi.org/10.71152/ajms.v16i2.4344
Rao SV, O'Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients with Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2025 Jun; 85(22): 2135-237. doi: 10.1161/CIR.0000000000001309. DOI: https://doi.org/10.1161/CIR.0000000000001309
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
